Universal Biosensors (UVBIF) Form 4 UNIVERSAL BIOSENSORS / Alastair Hodges ownership change

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Hodges Alastair

(Last) (First) (Middle)

1 CORPORATE AVENUE

ROWVILLE

(Street)

VICTORIA C3 3178

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
UNIVERSAL BIOSENSORS INC [ UBI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Scientist

3. Date of Earliest Transaction (Month/Day/Year)
10/24/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	10/24/2017		M		25,000	A	$0.00	2,871,615(12)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$0.5(1)							(11)	04/20/2023	Common Stock	742,000		742,000	D
Stock Option (Right to Buy)	$0.00							(2)	01/29/2022	Common Stock	40,000		40,000	D
Stock Option (Right to Buy)	$0.00							(3)	12/11/2020	Common Stock	40,000		40,000	D
Stock Option (Right to Buy)	$0.00							(4)	11/12/2019	Common Stock	25,000		25,000	D
Stock Option (Right to Buy)	$0.00							(5)	11/17/2018	Common Stock	25,000		25,000	D
Stock Option (Right to Buy)	$0.00	10/24/2017		M			25,000	(6)	11/10/2017	Common Stock	25,000	$0.00	0	D
Stock Option (Right to Buy)	$1.72(1)							(7)	11/09/2019	Common Stock	100,000		100,000	D
Stock Option (Right to Buy)	$0.00							(8)	06/28/2019	Common Stock	105,000		105,000	D
Stock Option (Right to Buy)	$0.00							(9)	05/14/2019	Common Stock	16,667		16,667	D
Stock Option (Right to Buy)	$0.89(1)							(10)	03/16/2018	Common Stock	100,000		100,000	D

Explanation of Responses:

1. The issue price reported is stated in Australian dollars.

2. 13,333 stock options vested and became exercisable on 12/31/2015, 13,333 stock options vested and became exercisable on 12/31/2016, and 13,334 stock options vest and become exercisable on 12/31/2017.

3. 13,333 stock options vested and became exercisable on 12/31/2014, 13,333 stock options vested and became exercisable on 12/31/2015, and 13,334 stock options vested and became exercisable on 12/31/2016.

4. 8,333 stock options vested and became exercisable on 12/31/2013, 8,333 stock options vested and became exercisable on 12/31/2014, and 8,334 stock options vested and became exercisable on 12/31/2015.

5. 8,333 stock options vested and became exercisable on 12/31/2012, 8,333 stock options vested and became exercisable on 12/31/2013, and 8,334 stock options vested and became exercisable on 12/31/2014.

6. 8,333 stock options vested and became exercisable on 12/31/2011, 8,333 stock options vested and became exercisable on 12/31/2012, and 8,334 stock options vested and became exercisable on 12/31/2013.

7. 1/3 of the stock options vested and became exercisable on 12/31/2010, 1/3 of the stock options vested and became exercisable on 12/31/2011 and the remaining stock options vested and became exercisable on 12/31/2012.

8. 10,000 stock options vested and became exercisable on 12/31/2010, 21,666 stock options vested and became exercisable on 12/31/2011, 35,000 stock options vested and became exercisable on 12/31/2012, 25,000 stock options vested and became exercisable on 12/31/2013, and 13,334 stock options vested and became exercisable on 12/31/2014.

9. 8,333 stock options vested and became exercisable on 12/31/2009 and were exercised on February 10, 2010. 8,333 stock options vested and became exercisable on 12/31/2010 and the remaining stock options vested and became exercisable on 12/31/11.

10. 1/3 of the stock options vested and became exercisable on 12/31/2008. 1/3 of the stock options vested and became exercisable on 12/31/2009. The remaining stock options vested and became exercisable on 12/31/2010.

11. 212,000 of the stock options vested and became exercisable on October 5, 2016, 424,000 of the stock options vested and became exerciseable on December 31, 2016 and 106,000 of the stock options vested and became exercisable on February 23, 2017.

12. Includes (i) 2,861,738 shares in the form of CDIs Dr. Hodges holds directly and (ii) 9,877 restricted fully paid shares.

Remarks:

	/s/ Cameron Billingsley, Attorney-in-Fact	10/26/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.